Making structural sense of dimerization interfaces of delta opioid receptor homodimers.
Opioid receptors, like other members of the G protein-coupled receptor (GPCR) family, have been shown to associate to form dimers and/or oligomers at the plasma membrane. Whether this association is stable or transient is not known. Recent compelling evidence suggests that at least some GPCRs rapidly associate and dissociate. We have recently calculated binding affinities from free energy estimates to predict transient association between mouse delta opioid receptor (DOR) protomers at a symmetric interface involving the fourth transmembrane (TM4) helix (herein termed "4" dimer). Here we present disulfide cross-linking experiments with DOR constructs with cysteines substituted at the extracellular ends of TM4 or TM5 that confirm the formation of DOR complexes involving these helices. Our results are consistent with the involvement of TM4 and/or TM5 at the DOR homodimer interface, but possibly with differing association propensities. Coarse-grained (CG) well-tempered metadynamics simulations of two different dimeric arrangements of DOR involving TM4 alone or with TM5 (herein termed "4/5" dimer) in an explicit lipid-water environment confirmed the presence of two structurally and energetically similar configurations of the 4 dimer, as previously assessed by umbrella sampling calculations, and revealed a single energetic minimum of the 4/5 dimer. Additional CG umbrella sampling simulations of the 4/5 dimer indicated that the strength of association between DOR protomers varies depending on the protein region at the interface, with the 4 dimer being more stable than the 4/5 dimer.
Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, New York 10029, United States.
Jennifer M
JM
Johnston
Mahalaxmi
M
Aburi
Davide
D
Provasi
Andrea
A
Bortolato
Eneko
E
Urizar
Nevin A
NA
Lambert
Jonathan A
JA
Javitch
Marta
M
Filizola
D000818:Animals; D057809:HEK293 Cells; D006801:Humans; D051379:Mice; D008958:Models, Molecular; D055503:Protein Multimerization; D020836:Protein Structure, Quaternary; D017465:Receptors, Opioid, delta / Q000737:chemistry* / Q000378:metabolism
C470381:DOR-1 protein, mouse; D017465:Receptors, Opioid, delta
Pharmacol Ther. 2001 Nov-Dec;92(2-3):71-87
11916530
Mol Pharmacol. 2009 Aug;76(2):264-74
19429716
Mol Pharmacol. 2005 Jun;67(6):2173-84
15778451
J Biol Chem. 2003 Feb 14;278(7):4385-8
12496294
Protein Eng. 2002 Nov;15(11):881-5
12538907
EMBO Rep. 2008 Apr;9(4):363-9
18344975
J Biol Chem. 2003 Sep 12;278(37):35345-53
12835319
Br J Pharmacol. 2008 Mar;153 Suppl 1:S216-29
17965750
Biochemistry. 2009 Oct 27;48(42):10020-9
19785461
Biochem J. 2002 Jul 15;365(Pt 2):429-40
11971762
Methods. 2007 Apr;41(4):475-88
17367719
J Mol Med (Berl). 2001 Jun;79(5-6):226-42
11485015
J Chem Theory Comput. 2008 Mar;4(3):435-47
26620784
J Chem Theory Comput. 2008 May;4(5):819-34
26621095
Biochemistry. 2003 Sep 23;42(37):11023-31
12974638
J Comput Chem. 2010 Apr 30;31(6):1333-43
20087907
J Mol Biol. 2007 Oct 19;373(2):503-19
17825317
Cell Signal. 2009 Jun;21(6):1015-21
19258039
Peptides. 2008 Aug;29(8):1424-31
18472184
Biochemistry. 2010 Aug 10;49(31):6771-6
20617813
Biopolymers. 2002;66(5):317-25
12539260
J Mol Biol. 1993 Dec 5;234(3):779-815
8254673
Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17495-500
16301531
Biochem Biophys Res Commun. 2007 May 11;356(3):642-7
17379184
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2693-8
20133736
Mol Pharmacol. 2001 Apr;59(4):774-83
11259622
J Biol Chem. 2001 Apr 27;276(17):14092-9
11278447
Biophys J. 1999 Jul;77(1):139-53
10388746
Science. 2007 Nov 23;318(5854):1258-65
17962520
J Biol Chem. 2003 Nov 14;278(46):45045-8
14519759
EMBO J. 2008 Sep 3;27(17):2293-304
18668123
Neuromolecular Med. 2005;7(1-2):51-9
16052038
Sci Signal. 2010 Mar 30;3(115):pe12
20354223
J Chem Phys. 2009 Feb 21;130(7):074101
19239278
Nat Chem Biol. 2009 Sep;5(9):688-95
19648932
J Biomed Opt. 2008 May-Jun;13(3):031208
18601532
Mol Pharmacol. 2007 Apr;71(4):1015-29
17220353
Nature. 2008 Mar 6;452(7183):93-7
18297054
Pharmacol Rev. 1996 Dec;48(4):567-92
8981566
Nat Immunol. 2004 Feb;5(2):216-23
14716309
Nat Methods. 2009 Mar;6(3):225-30
19234451
J Biol Chem. 1997 Oct 24;272(43):26959-64
9341132
J Chem Phys. 2008 Jun 14;128(22):227101; author reply 227102
18554067
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12043-8
12221291
Phys Rev Lett. 2008 Jan 18;100(2):020603
18232845
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5135-9
15044695
J Biol Chem. 2010 May 7;285(19):14514-20
20197280
Mol Pharmacol. 2004 Nov;66(5):1123-37
15304550
Mol Pharmacol. 2009 Jun;75(6):1296-9
19273553
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):117-22
14691245
J Phys Chem B. 2007 Jul 12;111(27):7812-24
17569554